Change in the Assumed Timing of COVID-19 Resolution to February 2022
First written in FY2021-Q3. 4 of 7 entries say "Restated". Latest entry: FY2023-Q3.
The whole theme swung hardest in 2026: 5 of 23 companies on the "Worse" side.
102 other companies' latest entry also says "Restated".
- FY2023-Q3RestatedAnnual report
「There have been no significant changes to the assumptions regarding the impact of COVID-19 described in the annual securities report for the previous consolidated fiscal year under “Significant Accounting Estimates.”」
The company has reconfirmed that there have been no material changes to the assumptions used for accounting estimates concerning the impact of COVID-19. - FY2023-Q2RestatedAnnual report
「There have been no significant changes to the assumptions regarding the impact of COVID-19 described in the annual securities report for the previous consolidated fiscal year under “Significant Accounting Estimates.”」
The company has reconfirmed that there have been no material changes to the assumptions used for accounting estimates concerning the impact of COVID-19. - FY2022Period of continued impact extended to the fiscal year ending June 2023Annual report
「The Group assumes that the impact of COVID-19 will continue for a certain period of the fiscal year ending June 2023.」
The assumption was changed from the previous assumption that the impact would continue for a certain period of the fiscal year ending June 2022 to one that it would continue for a certain period of the fiscal year ending June 2023. - FY2022-Q2Changed to an assumption that the domestic impact will continueAnnual report
「However, the outlook for economic recovery remains uncertain because of the renewed spread of infections caused by COVID-19 variants. In light of these circumstances, during the six-month period of the fiscal year ending June 2022, the Group made estimates, including for impairment of fixed assets and the recoverability of deferred tax assets, based on the assumption that the impact would continue in Japan for a certain period of the fiscal year ending June 2022.」
The assumption was changed from the previous assumption that conditions in Japan would recover and converge by the end of February 2022 to one that the impact of the infection would continue for a certain period of the fiscal year ending June 2022, and estimates were made accordingly. - FY2022-Q1RestatedAnnual report
「There have been no significant changes to the assumptions regarding the impact of COVID-19 described in the annual securities report for the previous consolidated fiscal year under “Significant Accounting Estimates.”」
The company has reconfirmed that there have been no material changes to the assumptions used for accounting estimates concerning the impact of COVID-19. - FY2021RestatedAnnual report
「The company assumes that, as vaccination progresses, conditions in Japan will gradually recover and converge by the end of February 2022,」
The assumption that COVID-19 would converge and recover by the end of February 2022 continues to be used in estimating impairment losses and deferred tax assets. - FY2021-Q3First statedAnnual report
「Regarding the impact of COVID-19, we had previously assumed that the situation would gradually resolve and recover by the end of the fiscal year ending June 2021. Because the timing of resolution remains uncertain, we changed the assumption to a gradual recovery and resolution by the end of February 2022 and used it in assessing the recoverability of deferred tax assets and impairment of fixed assets.」
The assumed timing of recovery and resolution was changed from the end of June 2021 to the end of February 2022 for impairment and deferred-tax-asset estimates.